Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of 8.33% and 785.93%, respectively, for the quarter ended March 2025. Do…
0,770€
6,21%
Echtzeit-Aktienkurs Clearside Biomedical Inc.
Bid:
Ask:
Nachrichten zur Clearside Biomedical Inc. Aktie
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of 23.08% and 13.33%, respectively, for the quarter ended December 2024. Do…
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
ALPHARETTA, Ga., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical…
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
ALPHARETTA, Ga., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
ALPHARETTA, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical, Inc. (CLSD) Suprachoroidal Space Drug Delivery (Transcript)
…
Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET
ALPHARETTA, Ga., July 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical, Inc. (CLSD) Q1 2024 Earnings Call Transcript
…
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical appoints new Chief Medical Officer By Investing.com
Clearside Biomedical appoints new Chief Medical Officer…
Earnings call: Clearside Biomedical reports on clinical trials and collaborations By Investing.com
Earnings call: Clearside Biomedical reports on clinical trials and collaborations…
Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript
…